VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$9.44
+1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4145.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 29.53x
- Price / sales
- 1955.03x
- Price / cash flow
- -11.51x
Enterprise value
- Enterprise value
- $256.2M
- EV / sales
- 1884.80x
- EV / EBITDA
- -10.08x
- EV / EBIT
- -8.78x
- Market cap
- $265.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026